Shares of Alkem Laboratories were trading at RS 5460.05, up by 58.50 points or 1.08% from the previous closing of RS 5401.55 on the BSE.

The stock opened at RS 5429.20 and touched an intraday high of RS 5538.35 and a low of RS 5384.50. A total of 1,894 shares were traded on the counter so far.

The BSE Group ‘A’ stock with a face value of RS 2 hit its 52-week high of RS 5933.00 on January 13, 2026, and a 52-week low of RS 4498.90 on February 28, 2025. Over the past week, the stock recorded a high of RS 5910.00 and a low of RS 5332.45. The company’s current market capitalization stands at RS 65677.05 crore.

In terms of shareholding, promoters hold 51.20% stake in the company, while Institutions and Non-Institutions account for 31.51% and 17.30%, respectively.

On the financial front, Alkem Laboratories reported a 13.96% decline in its standalone net profit at RS 622.14 crore for the third quarter ended December 31, 2025, compared to RS 723.12 crore in the same quarter of the previous year. However, the company’s total income rose 6.79% to RS 2622.80 crore in Q3FY26, up from RS 2456.01 crore in the corresponding quarter last year.

On a consolidated basis, the company posted a marginal increase in net profit to RS 636.02 crore for the quarter ended December 31, 2025, as against RS 625.82 crore in the year-ago period. Consolidated total income grew 11.90% to RS 3879.92 crore in Q3FY26, compared to RS 3467.27 crore in the corresponding quarter of the previous year.